Leveljump Healthcare Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Mitch Geisler

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	3.7yrs
Eigendom CEO	6.4%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	2.7yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Mitch Geisler's beloning veranderd ten opzichte van Leveljump Healthcare's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2023	n/a	n/a	-CA$1m
Jun 30 2023	n/a	n/a	CA$316k
Mar 31 2023	n/a	n/a	CA$253k
Dec 31 2022	CA$631k	CA$526k	CA$235k
Sep 30 2022	n/a	n/a	-CA$1m
Jun 30 2022	n/a	n/a	-CA$1m
Mar 31 2022	n/a	n/a	-CA$2m
Dec 31 2021	CA$354k	CA$240k	-CA$2m
Sep 30 2021	n/a	n/a	-CA$13m
Jun 30 2021	n/a	n/a	-CA$13m
Mar 31 2021	n/a	n/a	-CA$12m
Dec 31 2020	CA$217k	CA$168k	-CA$12m

Compensatie versus markt: Insufficient data to establish whether Mitch's total compensation is reasonable compared to companies of similar size in the German market.

Compensatie versus inkomsten: Mitch's compensation has increased whilst the company is unprofitable.

CEO

Mitch Geisler (54 yo)

3.7yrs

Tenure

CA$631,382

Compensatie

Mr. Mitchell Geisler, also known as Mitch, is Chief Executive Officer and Chairman of the Board at Leveljump Healthcare Corp. since December 9, 2020 and serves as its President. He has been the Chief Execu...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Mitchell Geisler	President	3.7yrs	CA$631.38k	6.36% € 202.5k
Robert Landau	CFO, Corporate Secretary & Director	3.7yrs	CA$631.38k	5.89% € 187.6k
Jacquelyn Glazer	Independent Director	2.7yrs	CA$9.60k	0.0025% € 79.2
Richard Jagodnik	Independent Director	2.7yrs	CA$9.60k	0.0021% € 65.9
Gurpreet Prihar	Independent Director	2.7yrs	CA$9.60k	0.058% € 1.8k
Alon Marantz	Member of Advisory Board	1.5yrs	geen gegevens	geen gegevens
Carlos de Sequeira	Member of Advisory Board	1.5yrs	geen gegevens	geen gegevens

2.7yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren bestuur: 75J's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Leveljump Healthcare Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Leveljump Healthcare Corp., Annual General Meeting, Oct 24, 2024

High number of new and inexperienced directors

No independent directors

Leveljump Healthcare Corp., Annual General Meeting, Jun 21, 2022

Recent updates

Leveljump Healthcare Corp., Annual General Meeting, Oct 24, 2024

Leveljump Healthcare Corp. (TSXV:JUMP) acquired ADC Imaging Inc.

Third quarter 2023 earnings released: CA$0.017 loss per share (vs CA$0.002 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.002 loss in 2Q 2022)

Leveljump Healthcare Corp. announced that it has received CAD 0.9 million in funding

Full year 2022 earnings released: EPS: CA$0.003 (vs CA$0.047 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.009 loss in 3Q 2021)

High number of new and inexperienced directors

Leveljump Healthcare Corp. announced that it expects to receive CAD 10 million in funding

Second quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.012 loss in 2Q 2021)

Leveljump Healthcare Corp. announced that it has received CAD 0.87875 million in funding

First quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.017 loss in 1Q 2021)

Full year 2021 earnings released: CA$0.047 loss per share (vs CA$4.36 loss in FY 2020)

No independent directors

Leveljump Healthcare Corp. (TSXV:JUMP) entered into an agreement to acquired additional 10.44% stake in Médical Temps Réel inc. for CAD 0.99 million.

Leveljump Healthcare Corp., Annual General Meeting, Jun 21, 2022

Leveljump Healthcare Corp. (TSXV:JUMP) acquired a 10.8% stake in Shaw Lens Inc./Shaw Vision Inc. from minority shareholders for $0.104 million.

Leveljump Healthcare Corp. announced that it expects to receive CAD 2 million in funding

Leveljump Healthcare Corp. announced that it has received CAD 1.524284 million in funding

Leveljump Healthcare Corp. announced that it has received CAD 0.477785 million in funding

Leveljump Healthcare Corp. (TSXV:JUMP) completed the acquisition of Three Diagnostic Imaging Clinics Located in Ontario.

Leveljump Healthcare Corp. announced that it expects to receive CAD 2.5 million in funding

Leveljump Healthcare Corp. (TSXV:JUMP) agreed to acquire additional 7.82% in Real Time Medical Inc. for CAD 0.15 million

Leveljump Healthcare Corp. Receives Ministry of Health Grants Approval for License Transfer of IHF to Jump

Leveljump Healthcare Corp. (TSXV:JUMP) completed the acquisition of 14.6% stake in Real Time Medical.

Third quarter 2021 earnings: Revenues in line with analyst expectations

Leveljump Healthcare Corp. (TSXV:JUMP) offered to acquire 19.9% stake in Real Time Medical.

Leveljump Healthcare Corp. announced that it expects to receive CAD 1.48142 million in funding

Leveljump Healthcare Corp. (TSXV:JUMP) acquired 23.8% stake in Shaw Lens Inc. and Shaw Vision Inc. for CAD 0.13 million.

Second quarter 2021 earnings released: CA$0.012 loss per share

Leveljump Healthcare Corp. announced that it has received CAD 0.1 million in funding

Leveljump Healthcare Corp. announced that it expects to receive CAD 0.1 million in funding

Leveljump Healthcare Corp. announced that it has received CAD 1.5 million in funding

Leveljump Healthcare Corp. announced that it expects to receive CAD 1.5 million in funding

Full year 2020 earnings released: CA$4.36 loss per share

LevelJump Healthcare Corp. Provides Financial Guidance for 2021